Medtronic’s renal denervation system demonstrates positive results
As part of the firm’s SPYRAL HTN Global Clinical Programme, the three-year data from SPYRAL HTN-ON MED and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 May 22
As part of the firm’s SPYRAL HTN Global Clinical Programme, the three-year data from SPYRAL HTN-ON MED and…
18 May 22
Funds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels
16 May 22
Medtronic said Onyx Frontier DES has undergone meaningful design changes, including enhanced catheter flexibility, advanced dual-layer balloon technology…
16 May 22
The AcQForce Flutter trial was designed to assess the safety and efficacy of the company’s AcQBlate FORCE sensor…
11 May 22
The study was designed to analyse the safety and feasibility of the CAPTIS device in patients undergoing Transcatheter…
11 May 22
The device delivers CCM therapy to the heart by sending timed electrical pulses to the heart, allowing more…
04 May 22
KardiaComplete is an enterprise solution for employers, health insurance plans and health systems to improve heart health and…
02 May 22
In the study, 89% of patients treated with the company’s TactiCath SE for persistent AFib experienced no symptoms…
02 May 22
The double-blind, randomised, controlled Safe and Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D) clinical trial is expected to enrol…
02 May 22
Xcardia Innovation Ltd. is a private medical device company developing innovative cardiovascular technologies